肽诱导细胞凋亡的机制尚不完全清楚主要原因可能是 能阻断整合蛋白信...
Source:Pichia.Pastoris
MolecularWeight:RecombinantOPG/Fccontains412aminoacidresidues,including180residuesfrommatureOPG(a.a22-201)and232residuesfromtheFcproteinofhumanIgG1,andhasacalculatedmolecularmassof46.5kDa.Asaresultofglycosylation,therecombinantOPG/Fcmigratesasa49kDaproteininSDS-PAGEunderreducingconditions.
Purity:>90%bySDS-PAGEandHPLCanalyses.
AASequence:OPG22-201:
ETFPPKYLHYDEETSHQLLCDKCPPGTYLKQHCTAKWKTVCAPCPDHYYTDSWHTSDECLYCSPVCKELQYVKQECNRTHNRVCECKEGRYLEIEFCLKHRSCPPGFGVVQAGTPERNTVCKRCPDGFFSNETSSKAPCRKHTNCSVFGLLLTQKGNATHDNICSGNSESTQKCGIDVTL
Fc232:
EPKSSDKTHTCPPCPAPEFEGAPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPTPIEKTISKAKGQREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
BiologicalActivity:Fullybiologicallyactivewhencomparedtothestandard.DeterminedbyitsabilitytoneutralizethestimulationofU937cellstreatedwith10ng/mlofsolubleRANKL.
Formulation:Lyophilizedfroma0.2μmfilteredconcentrated(0.5mg/ml)solutioninPBS,pH7.4.
Endotoxin:Lessthan1EU/μgofrHuOPG-FcasdeterminedbyLALmethod.
Reconstitution:Werecommendthatthisvialbebrieflycentrifugedpriortoopeningtobringthecontentstothebottom.Reconstituteinsteriledistilledwateroraqueousbuffercontaining0.1%BSAtoaconcentrationof0.1-1.0mg/mL.Stocksolutionsshouldbeapportionedintoworkingaliquotsandstoredat<-20°C. Further dilutions should be made in appropriate buffered solutions.
Storage:Thislyophilizedpreparationisstableat2-8°C,butshouldbekeptat-20°Cforlongtermstorage,preferablydesiccated.Uponreconstitution,thepreparationisstableforuptooneweekat2-8°C.Formaximalstability,apportionthereconstitutedpreparationintoworkingaliquotsandstoreat-20°Cto-70°C.Avoidrepeatedfreeze/thawcycles.
Usage:Thismaterialisusedforresearch,laboratoryorfurtherevaluationpurposes.NOTFORHUMANUSE.
HumanOsteoprotegerin
Osteoprotegerin(OPG)isamemberoftheTNFRsuperfamilythatcanactasadecoyreceptorforRANKL.BindingofsolubleOPGtosRANKLinhibitsosteoclastogenesisbyinterruptingthesignalingbetweenstromalcellsandosteoclasticprogenitorcells,therebyleadingtoexcessaccumulationofboneandcartilage.OPGisexpressedinawidevarietyoftissuesincludingadultheart,lung,kidney,liver,spleen,prostate,lymphnodeandbonemarrow.OPGissecretedbothasamonomericandadimericprotein.Itsprimarystructureconsistsofsevendistinctdomains,fourofwhichcorrespondstotheextracellularcysteine-richdomainsofTNFRproteinsandconstitutesthesolubleOPG.
MolecularWeight:RecombinantOPG/Fccontains412aminoacidresidues,including180residuesfrommatureOPG(a.a22-201)and232residuesfromtheFcproteinofhumanIgG1,andhasacalculatedmolecularmassof46.5kDa.Asaresultofglycosylation,therecombinantOPG/Fcmigratesasa49kDaproteininSDS-PAGEunderreducingconditions.
Purity:>90%bySDS-PAGEandHPLCanalyses.
AASequence:OPG22-201:
ETFPPKYLHYDEETSHQLLCDKCPPGTYLKQHCTAKWKTVCAPCPDHYYTDSWHTSDECLYCSPVCKELQYVKQECNRTHNRVCECKEGRYLEIEFCLKHRSCPPGFGVVQAGTPERNTVCKRCPDGFFSNETSSKAPCRKHTNCSVFGLLLTQKGNATHDNICSGNSESTQKCGIDVTL
Fc232:
EPKSSDKTHTCPPCPAPEFEGAPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPTPIEKTISKAKGQREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
BiologicalActivity:Fullybiologicallyactivewhencomparedtothestandard.DeterminedbyitsabilitytoneutralizethestimulationofU937cellstreatedwith10ng/mlofsolubleRANKL.
Formulation:Lyophilizedfroma0.2μmfilteredconcentrated(0.5mg/ml)solutioninPBS,pH7.4.
Endotoxin:Lessthan1EU/μgofrHuOPG-FcasdeterminedbyLALmethod.
Reconstitution:Werecommendthatthisvialbebrieflycentrifugedpriortoopeningtobringthecontentstothebottom.Reconstituteinsteriledistilledwateroraqueousbuffercontaining0.1%BSAtoaconcentrationof0.1-1.0mg/mL.Stocksolutionsshouldbeapportionedintoworkingaliquotsandstoredat<-20°C. Further dilutions should be made in appropriate buffered solutions.
Storage:Thislyophilizedpreparationisstableat2-8°C,butshouldbekeptat-20°Cforlongtermstorage,preferablydesiccated.Uponreconstitution,thepreparationisstableforuptooneweekat2-8°C.Formaximalstability,apportionthereconstitutedpreparationintoworkingaliquotsandstoreat-20°Cto-70°C.Avoidrepeatedfreeze/thawcycles.
Usage:Thismaterialisusedforresearch,laboratoryorfurtherevaluationpurposes.NOTFORHUMANUSE.
HumanOsteoprotegerin
Osteoprotegerin(OPG)isamemberoftheTNFRsuperfamilythatcanactasadecoyreceptorforRANKL.BindingofsolubleOPGtosRANKLinhibitsosteoclastogenesisbyinterruptingthesignalingbetweenstromalcellsandosteoclasticprogenitorcells,therebyleadingtoexcessaccumulationofboneandcartilage.OPGisexpressedinawidevarietyoftissuesincludingadultheart,lung,kidney,liver,spleen,prostate,lymphnodeandbonemarrow.OPGissecretedbothasamonomericandadimericprotein.Itsprimarystructureconsistsofsevendistinctdomains,fourofwhichcorrespondstotheextracellularcysteine-richdomainsofTNFRproteinsandconstitutesthesolubleOPG.
免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。
发布于 : 2021-07-16
阅读(298)
▍
相关分类
▍
相关文章
PCR引物的设计原则
Taqman探针及SYBR Green I荧光染料技术金锄头文库
为什么选择MR™ | MR™ 高折射率镜片材料 | 三井化学株式会社
目的基因克隆的筛选与鉴定 实验方法
(6分)右图是显微镜结构图,请根据图回答:(1)调节视野亮度的结构是...
便携式atp荧光检测仪如何选择_制药网
用于表达黄病毒科蛋白的重组慢病毒载体及其作为疫苗的应用专利查询/...
Biorad Gene Pulser Xcell电穿孔系统(中文)
肽诱导细胞凋亡的机制尚不完全清楚主要原因可能是 能阻断整合蛋白信...
namiki==的个人空间 ( ゜ ゜)つロ 乾杯~ Bilibili
药剂学实验教案——流浸膏、浸膏及煎膏的制备(人卫版)
流式细胞仪实验方法及常见问题分析
▍
相关问答
